Global L-carnitine market is expected to grow over the forecast period owing to increasing incidences of diseases such as congestive heart failure, heart attacks, Rett syndrome, anorexia, diabetes and thyroid. Other high impact rendering driver for growth of this market is rising geriatric population base globally coupled with greater spending ability of health conscious people. Increasing use of L-carnitine in health drinks, food supplements, and medicines has further fuelled its market growth over the past few years and the trend is likely to prevail over the forecast period. Other drivers of this market include unhealthy lifestyle and increasing patient awareness towards timely treatment of various disorders.
L-carnitine is an amino acid which is naturally produced in the body and helps the body produce energy. Its supplements are used to increase energy levels in carnitine deficient patients. It is also used as a supplement in strict vegetarians, dieters, and pre-mature infants. L-carnitine is naturally found in foods such as red meat, dairy products, avocados, peanut butter and fish. The market for carnitine is segmented on the basis of benefits derived which include fat loss, improved heart conditions, kidney treatment, boosting immunity and improving male infertility, brain function and bone mass. Among these, obesity control segment holds the largest share owing to rising prevalence of unhealthy lifestyle among the global population. Furthermore, obesity related complications such as diabetes, chronic fatigue and heart attacks contribute towards dominance of this segment. Global market has witnessed increasing number of new entrants in the food manufacturing sector owing to potential of L-carnitine in improving athletic performance. Studies suggest that L-carnitine offers significant benefits to help enhance the overall quality of life.
North America dominated the global L-carnitine market in 2013 on account of high prevalence of obesity among the population base and rising occurrences of related issues. Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to low prices, increasing manufacturing capacity and high quality standards. Low consumer awareness and misleading information are expected to be key constraints for market development over the forecast period.
The key players in the L-carnitine market include Northeast Pharmaceutical Group Co., Ltd., AIDP Inc., Alfa Aesar, Spectrum Chemicals and Laboratory Products, Inc., Zhejiang Jiashan Chengda Pharm & Chem Co., Ltd., Biosynth AG, Wuhan Yuancheng Technology Development Co., Ltd., Zhejian Jiashan Chengda Pharm Co. Ltd., Lonza Group Ltd., Qingdao FTZ United International Inc., Sigma–Tau Pharmaceuticals , Inc., Ajinomoto AminoScience LLC and Ningbo Honor Chemtech Co., Ltd. Sharp attention towards effective marketing of L-carnitines’ health benefits is expected to positively impact its market demand and ensure its recognition as a key product in weight management ingredient market.
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.